Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
225.5 USD | +0.08% | +2.83% | -13.01% |
May. 09 | MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman | RE |
May. 08 | Redburn Atlantic Adjusts Price Target on Biogen to $235 From $275, Keeps Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.01% | 32.81B | |
-2.47% | 89.37B | |
+2.76% | 40.65B | |
+52.41% | 25B | |
-17.31% | 15.29B | |
-42.45% | 11.61B | |
-10.48% | 11.49B | |
+6.14% | 8.98B | |
-7.72% | 8.23B | |
-7.37% | 7B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Biogen : Preliminary Analysis Suggests Certain Multiple Sclerosis Therapies May Reduce COVID-19 Vaccine Antibody Response